Using Clinical Measures of Disease Control to Reduce the Burden of Asthma
暂无分享,去创建一个
[1] K. Rabe,et al. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. , 2000, The European respiratory journal.
[2] M. Kochen,et al. Evaluating an educational intervention to improve the treatment of asthma in four European countries. Drug Education Project Group. , 1999, American journal of respiratory and critical care medicine.
[3] U. Gerdtham,et al. Impact of inhaled corticosteroids on asthma hospitalization in Sweden , 1996 .
[4] S. Thompson. On the social cost of asthma. , 1984, European journal of respiratory diseases. Supplement.
[5] C. Jenkins,et al. Salmeterol/fluticasone propionate combination therapy 50/250 microg twice daily is more effective than budesonide 800 microg twice daily in treating moderate to severe asthma. , 2000, Respiratory medicine.
[6] J. Bousquet,et al. Is overall asthma control being achieved? A hypothesis-generating study. , 2001, The European respiratory journal.
[7] G H Guyatt,et al. Development and validation of a questionnaire to measure asthma control. , 1999, The European respiratory journal.
[8] H. Anttila,et al. Salmeterol/fluticasone propionate (50/100 μg) in combination in a Diskus™ inhaler (Seretide™) is effective and safe in children with asthma , 2000, Pediatric pulmonology.